Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-21

FDA Approved: BROMFENAC OPHTHALMIC SOLUTION 0.09% — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Bromfenac Ophthalmic Solution 0.09% as an Original Application (ANDA) for ophthalmic use, marking a generic version of bromfenac for postoperative …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromfenac ophthalmic solution 0.09% (bromfenac)

Snippet

ORIG AP for BROMFENAC OPHTHALMIC SOLUTION 0.09% (BROMFENAC OPHTHALMIC SOLUTION 0.09%)